Rapid drying of retinal fluid with faricimab injections may help identify patients with neovascular age-related macular degeneration who can safely extend time between injections.
First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to ...
Intraocular Implant Shows Promise in Treating Dry ARMD An intraocular implant designed to secrete therapeutic doses of CNTF in the eye is a promising new treatment of dry ARMD. David M. Brown, MD, ...
New research highlights progress in treating age-related macular degeneration, including late‑stage drug trials, gene therapy strategies, and a wireless retinal prosthesis that restored limited ...
A two-square-millimeter chip has corrected the damage from advanced atrophic age-related macular degeneration (AMD), the leading cause of irreversible blindness in adults. After being treated with an ...
MELBOURNE, Australia, and Princeton, N.J., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel ...
(BPT) - Age-related macular degeneration (AMD) once meant a slow, irreversible loss of vision, and many people still believe that's true. But the AMD of today isn't the AMD of a generation ago.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results